262 related articles for article (PubMed ID: 34874911)
1. Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.
Seebauer CT; Graus MS; Huang L; McCann A; Wylie-Sears J; Fontaine F; Karnezis T; Zurakowski D; Staffa SJ; Meunier F; Mulliken JB; Bischoff J; Francois M
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34874911
[TBL] [Abstract][Full Text] [Related]
2. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
3. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
[TBL] [Abstract][Full Text] [Related]
4. Propranolol Accelerats Hemangioma Stem Cell Transformation Into Adipocyte.
Li HH; Lou Y; Zhang RR; Xie J; Cao DS
Ann Plast Surg; 2019 Nov; 83(5):e5-e13. PubMed ID: 31609806
[TBL] [Abstract][Full Text] [Related]
5. A transcription factor is the target of propranolol treatment in infantile hemangioma.
Schrenk S; Boscolo E
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 35104803
[TBL] [Abstract][Full Text] [Related]
6. R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma.
Overman J; Fontaine F; Wylie-Sears J; Moustaqil M; Huang L; Meurer M; Chiang IK; Lesieur E; Patel J; Zuegg J; Pasquier E; Sierecki E; Gambin Y; Hamdan M; Khosrotehrani K; Andelfinger G; Bischoff J; Francois M
Elife; 2019 Jul; 8():. PubMed ID: 31358114
[TBL] [Abstract][Full Text] [Related]
7. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma.
Boscolo E; Mulliken JB; Bischoff J
Am J Pathol; 2011 Nov; 179(5):2266-77. PubMed ID: 21945324
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective vascular effects of the (R)- and (S)-enantiomers of propranolol and atenolol.
Stoschitzky K; Lindner W; Kiowski W
J Cardiovasc Pharmacol; 1995 Feb; 25(2):268-72. PubMed ID: 7752652
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid luteolin suppresses infantile hemangioma by targeting FZD6 in the Wnt pathway.
Dai Y; Zheng H; Liu Z; Wang Y; Hu W
Invest New Drugs; 2021 Jun; 39(3):775-784. PubMed ID: 33411210
[TBL] [Abstract][Full Text] [Related]
10. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation.
Boscolo E; Stewart CL; Greenberger S; Wu JK; Durham JT; Herman IM; Mulliken JB; Kitajewski J; Bischoff J
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2181-92. PubMed ID: 21757656
[TBL] [Abstract][Full Text] [Related]
11. β-blocker therapy for infantile hemangioma.
Koh SP; Leadbitter P; Smithers F; Tan ST
Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
[TBL] [Abstract][Full Text] [Related]
12. Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.
Lorusso B; Cerasoli G; Falco A; Frati C; Graiani G; Madeddu D; Nogara A; Corradini E; Roti G; Cerretani E; Gherli A; Caputi M; Gnetti L; Pilato FP; Quaini F; Lagrasta C
Vascul Pharmacol; 2022 Oct; 146():107110. PubMed ID: 36103993
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
[TBL] [Abstract][Full Text] [Related]
14. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
[TBL] [Abstract][Full Text] [Related]
15. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
[TBL] [Abstract][Full Text] [Related]
16. E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma.
Smadja DM; Mulliken JB; Bischoff J
Am J Pathol; 2012 Dec; 181(6):2239-47. PubMed ID: 23041613
[TBL] [Abstract][Full Text] [Related]
17. Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade.
Moisan F; Oucherif S; Kaulanjan-Checkmodine P; Prey S; Rousseau B; Bonneu M; Claverol S; Gontier E; Lacomme S; Dousset L; Couffinhal T; Toutain J; Loot M; Cario-André M; Jullié ML; Léauté-Labrèze C; Taieb A; Rezvani HR
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33558238
[TBL] [Abstract][Full Text] [Related]
18. A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas.
Zhao ZL; Liu C; Wang QZ; Zhang WB; Shao L; Wu HW; Zheng JW
Medicine (Baltimore); 2021 Jan; 100(1):e24146. PubMed ID: 33429792
[TBL] [Abstract][Full Text] [Related]
19. Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth.
Guo X; Zhu X; Liu D; Gong Y; Sun J; Dong C
Int J Nanomedicine; 2017; 12():6923-6936. PubMed ID: 29075111
[TBL] [Abstract][Full Text] [Related]
20. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Pan WK; Li P; Guo ZT; Huang Q; Gao Y
Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
